Page last updated: 2024-11-11

13-hydroperoxy-9,11,15-octadecatrienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

13-hydroperoxy-9,11,15-octadecatrienoic acid: structure given in first source; RN given refers to (E,Z,Z)-isomer; RN for cpd without isomeric designation not available 11/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6440263
SCHEMBL ID4611998
MeSH IDM0160582

Synonyms (6)

Synonym
(9e,11e,15e)-13-hydroperoxyoctadeca-9,11,15-trienoic acid
28836-09-1
13-hydroperoxy-9,11,15-octadecatrienoic acid
9,11,15-octadecatrienoic acid, 13-hydroperoxy-, (e,z,z)-
SCHEMBL4611998
(9z11e15z13s)-13-hydroperoxy-9,11,15-octadecatrienoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's4 (21.05)18.2507
2000's7 (36.84)29.6817
2010's5 (26.32)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]